Histamine-2 (H 2 ) antagonists can be safely removed from standard paclitaxel premedication regimens.

Published in: British journal of clinical pharmacology (2022)

antagonists do not confer any advantage as part of premedication regimens in reducing the incidence of HSR in patients treated with paclitaxel.

Keyphrases